Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Signify Health, Inc. (NYSE:SGFY – Get Rating) by 12.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,134 shares of the company’s stock after buying an additional 1,250 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Signify Health were worth $319,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Wolverine Asset Management LLC grew its position in shares of Signify Health by 127.9% in the 4th quarter. Wolverine Asset Management LLC now owns 122,714 shares of the company’s stock worth $3,517,000 after buying an additional 68,879 shares during the period. Trium Capital LLP purchased a new stake in shares of Signify Health in the 4th quarter worth about $6,664,000. Strs Ohio grew its position in shares of Signify Health by 1,802.8% in the 4th quarter. Strs Ohio now owns 441,009 shares of the company’s stock worth $12,639,000 after buying an additional 417,832 shares during the period. Dupont Capital Management Corp grew its position in shares of Signify Health by 174.8% in the 4th quarter. Dupont Capital Management Corp now owns 137,900 shares of the company’s stock worth $3,952,000 after buying an additional 87,709 shares during the period. Finally, Calamos Advisors LLC purchased a new stake in shares of Signify Health in the 4th quarter worth about $12,684,000. 89.99% of the stock is owned by hedge funds and other institutional investors.
Signify Health Stock Performance
Shares of NYSE SGFY opened at $30.49 on Wednesday. The firm’s 50-day moving average price is $29.72 and its 200-day moving average price is $29.08. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.41. The company has a market cap of $7.21 billion, a PE ratio of -9.27 and a beta of 0.37. Signify Health, Inc. has a 52-week low of $10.70 and a 52-week high of $30.50.
Analyst Upgrades and Downgrades
Separately, TheStreet downgraded shares of Signify Health from a “c-” rating to a “d” rating in a research report on Monday, February 13th. Nine research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat, Signify Health currently has a consensus rating of “Hold” and a consensus target price of $28.67.
Signify Health Profile
(Get Rating)
Signify Health, Inc operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient’s home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.
Featured Articles
Want to see what other hedge funds are holding SGFY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Signify Health, Inc. (NYSE:SGFY – Get Rating).
Receive News & Ratings for Signify Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Signify Health and related companies with MarketBeat.com’s FREE daily email newsletter.